GLP1R Agonist (CRISPR Therapeutics)

N/A

Report date: 2026/05/11 20:01:57

Base Information

Drug NameGLP1R Agonist (CRISPR Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDyslipidemiasMetabolic Syndrome +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrispr Therapeutics Ag
China Registration ClassN/A

Develop Information

Active CompaniesCrispr Therapeutics Ag
Inactive CompaniesN/A
Active IndicationsObesityDyslipidemiasMetabolic Syndrome +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A